USPTO serial 79193284
ZENIT
Reviewed by CopyMark Law Group
Reg. 5326360Status 709
- Filing date
- Status date
- Registration date
- Nov 7, 2017
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ZENIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew D. Asbell
Matthew D. Asbell Ladas & Parry LLP1040 Avenue of the AmericasNew York, NY 10018-3738UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Diagnostic apparatus for laboratory or research use for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates; diagnostic equipment for scientific or laboratory use, namely, for detecting antibodies; diagnostic apparatus for the detection of antibodies for laboratory or scientific research use; diagnostic equipment for scientific or laboratory use, namely, microplate and glass slide processors; diagnostic equipment for scientific or laboratory use, namely, microplate readers; diagnostic equipment for scientific or laboratory use, namely, plates, glass slides and chips having multi-well arrays that can be used in chemical analysis and biological analysis for patterning; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates, the diagnostic apparatus having as an integral component, preloaded software that enables image capture and storage, immunofluorescence detection, pattern recognition, and automated analysis; diagnostic equipment for scientific or laboratory use for detecting antibodies, the diagnostic equipment having as an integral component, preloaded software for automating enzyme linked immunosorbent assay, immunofluorescence assay and microarray methods; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates, the diagnostic apparatus having as an integral component, preloaded software for the detection of antibodies for laboratory or research use; diagnostic equipment for scientific or laboratory use, namely, microplate processors and glass slide processors, the diagnostic equipment having as an integral component, preloaded software for automating enzyme linked immunosorbent assay, immunofluorescence assay and microarray methods | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus for automatically diagnosing, reading and interpreting specimens by indirect immunofluorescence on cell substrates; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes; medical apparatus for automatically diagnosing, reading and interpreting specimens by indirect immunofluorescence on cell substrates, the medical apparatus having as an integral component, preloaded software that enables image capture and storage, immunofluorescence detection, pattern recognition, and automated analysis; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases, the medical diagnostic apparatus having as an integral component, preloaded software for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids, the medical diagnostic instruments having as an integral component, preloaded software for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes, the immunological analyzers having as an integral component preloaded software for detecting immune system components; hematology analyzers for medical diagnostic purposes, the hematology analyzers having as an integral component preloaded software for blood cell analysis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named ZENIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 29, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 29, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 24, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 24, 2024 | C71T | CANCELLED SECTION 71 | — |
| Nov 7, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 13, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 14, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 7, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 7, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 22, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 18, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 2, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 2, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 2, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 14, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 14, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 14, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 7, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 3, 2017 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 3, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 9, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 9, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 18, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 16, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 6, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |